Company profile: Mimetas
1.1 - Company Overview
Company description
- Provider of predictive Organ-on-a-Chip cell culture tissue and disease models via its OrganoPlates featuring organotypic screening models, improving predictability over in vitro and animal models to enable better, more reliable, and tailored medicines.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Mimetas
TetraVitae Bioscience
HQ: United States
Website
- Description: Provider of biobased chemicals, plastics, and fuels designed to replace petroleum-derived products, leveraging proprietary technology in industrial fermentations, process engineering, microbiology, and cellulosic feedstocks to lower production costs and enable competitive alternatives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TetraVitae Bioscience company profile →
Nortis Bio
HQ: United States
Website
- Description: Provider of organ-on-a-chip systems and tissue-engineering techniques that create human micro-tissue environments within small, disposable microfluidic chips, enabling living models of human organs to accelerate discovery and help scientists better understand the causes of human diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nortis Bio company profile →
Aushon Biosystems
HQ: United States
Website
- Description: Provider of robust protein biomarker assay development, detection, and analysis via a multiplex immunoassay platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aushon Biosystems company profile →
Algonomics
HQ: Belgium
Website
- Description: Provider of structural bioinformatics services to develop rationally designed therapeutics in immunotherapy, leveraging a proprietary platform for structure-based protein and peptide design. Belgium-based biotech.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Algonomics company profile →
Comecer
HQ: Italy
Website
- Description: Provider of protection technologies in nuclear medicine, isolation, and nuclear power plant equipment, and of screening systems for special applications serving hospitals, universities, industrial groups, and research organizations. Products include aseptic processing and containment systems, a Terbium-161 production line, the IRIS radiopharmaceutical injection system, THERABED protected admission management, ISP radioactive waste management, and dose calibrators.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comecer company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Mimetas
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Mimetas
2.2 - Growth funds investing in similar companies to Mimetas
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Mimetas
4.2 - Public trading comparable groups for Mimetas
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →